PTGS2 and epilepsy: In rodent models of cognitive impairment in diabetic rats [28] and pentylenetetrazol-induced experimental epilepsy, meloxicam showed notable neuroprotection and rescued the behavioral deficits by dampening TNF-α and interleukins together with COX-2/PGE2 pathway [50].